AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia Marketed under AQVESME brand name in the U.S. for ...

From iron and protein to vitamin C pairings, experts explain how everyday food choices can improve haemoglobin levels and ...

Operational real-world data analyzed from patients prescribed ZYNTEGLO™ and LYFGENIA™Data demonstrates the value proposition of one-time, durable gene therapy for the treatment of sickle cell disease ...

Thalassemia is a hereditary blood disorder that silently passes from parents to their children. Understanding its symptoms, ...

Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of long-term hematopoietic stem cells (LT-HSCs) with at least one ...

CAMBRIDGE, Mass., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced new ...

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

There may be an evolutionary thread linking big brains, long lifespans and immune-system genes in mammals, a new study finds. An organism’s lifespan depends partly on its genes, but scientists have ...

Weatherall, D. J., The Thalassaemia Syndromes (Blackwell Scientific Publications, Oxford, 1965).

*Tel.: +98 311 3913382. Fax: +98 311 3912254. E-mail address: [email protected]. Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) ...

If you have two copies of the same version of a gene, you are homozygous for that gene. If you have two different versions of a gene, you are heterozygous for that gene. In diseases caused by dominant ...

"WHO THE HELL LIED TO ME": 29 Hilarious Fails From Last Week That Made Me Laugh So Hard I Burned Off All My Thanksgiving ...